Rotavirus vaccines have demonstrated impact in reducing diarrheal morbidity and mortality
worldwide. As countries begin to introduce the newly prequalified vaccines, additional data …

Background Rotavirus results in more diarrhoea‐related deaths in children under five years
than any other single agent in countries with high childhood mortality. It is also a common …

Vaccines against COVID-19 are being developed at speeds not previously achieved. With
this unprecedented effort comes challenges for post-marketing safety monitoring and …

Background Understanding the safety of vaccines is critical to inform decisions about
vaccination. Our objective was to conduct a systematic review of the safety of vaccines …

Background A monovalent, parenteral, subunit rotavirus vaccine was well tolerated and
immunogenic in adults in the USA and in toddlers and infants in South Africa, but elicited …

Group A rotaviruses (RVAs) are the leading cause of gastroenteritis, causing 0.2 million
deaths and several million hospitalisations globally each year. Four rotavirus vaccines …

Rotavirus remains a leading cause of diarrhoeal morbidity and mortality in young children
and rotavirus vaccines are critical for reducing global disease burden. This report addresses …

Background Rotavirus is a common cause of diarrhoea, diarrhoea‐related hospital
admissions, and diarrhoea‐related deaths worldwide. Rotavirus vaccines prequalified by …

Background In some countries that have introduced oral rotavirus vaccines, a small but
elevated risk of intussusception—a rare bowel disorder—has been reported. Updated …

Rotavirus is the leading cause of severe dehydrating gastroenteritis and death due to
diarrhea among children under 5, causing over 180,000 under-5 deaths annually. Safe …